September 13, 2006
WEST SACRAMENTO, Calif., September 13, 2006 -- Lipomics Technologies, Inc., a
privately held company that specializes in lipid metabolite analysis and interpretation,
today announced that it has been competitively selected to receive a Phase II Small
Business Technology Transfer Grant from the Department of Defense to improve the
optimum fitness and performance of combat personnel. The study findings will be used to
develop diagnostic tools that will evaluate an individual soldier’s readiness for training
and predict the potential for injury during times of physical stress. The study findings will
also be evaluated for their diagnostic potential in physical fitness programs of the general
population.
Collaborating with the University of California, Davis, and Arête Therapeutics, Inc.,
Phase I of the study, conducted last year, employed validated metabolomic analysis
platforms to determine how metabolic profiles can predict performance, metabolic stress,
fatigue, and recovery rates for individuals undergoing extreme exertion. Phase II and III
of this study will be performed by Dr. Patricia Deuster at the Uniformed Services
University of Health Science.
“An objective measure of our war-fighters' physical and psychological wellbeing will
promote optimal military performance, avoid the deleterious consequences of fatigue, and
potentially reduce the risk of injury,” said Dr. Deuster.
Lipomics will be applying its years of accumulated knowledge in evaluating metabolic
response to produce a practical, personalized diagnostic test that will help improve
training regimens, dietary guidance and if necessary, therapeutic interventions to
optimize their preparedness prior to and recovery after exhaustive activity. The
development of this test will advance Lipomics’ strategic vision of creating a suite of
commercially available diagnostic assays based on metabolic profiles for health, fitness
and disease.